Tribunal in NAFTA arbitration between Eli Lilly and the Canadian government has found the application of the promise doctrine did not involve a fundamental change in the country’s patent law, in a keenly-anticipated decision
Unlock this content.
The content you are trying to view is exclusive to our subscribers.
Paul Ainsworth, who secured a settlement for his client in a patent dispute, says the case shows why medical claims by dietary supplement companies can threaten IP rights
In major recent developments, a confidentiality request was rejected, Samsung and its representative A&O Shearman secured a partial win, and EIP made a new hire